BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 3211434)

  • 1. A rapid method for the preparation of 99Tcm hexametazime-labelled leucocytes.
    Solanki KK; Mather SJ; Janabi MA; Britton KE
    Nucl Med Commun; 1988 Oct; 9(10):753-61. PubMed ID: 3211434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The development of a clinical protocol for the radiolabelling of mixed leucocytes with 99Tcm-hexamethylpropyleneamine oxime.
    Danpure HJ; Osman S; Carroll MJ
    Nucl Med Commun; 1988 Jun; 9(6):465-75. PubMed ID: 3412734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 99Tcm-HMPAO labelled leucocytes: comparison with 111In-tropolonate labelled granulocytes.
    Peters AM; Roddie ME; Danpure HJ; Osman S; Zacharopoulos GP; George P; Stuttle AW; Lavender JP
    Nucl Med Commun; 1988 Jun; 9(6):449-63. PubMed ID: 3412733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 99Tcm hexamethylpropyleneamineoxime (HMPAO) as a platelet label: evaluation of labelling parameters and first in vivo results.
    Becker W; Börner W; Borst U
    Nucl Med Commun; 1988 Oct; 9(10):831-42. PubMed ID: 3211441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of 99Tcm-HMPAO and 111In-oxine labelled granulocytes in man: first clinical results.
    Becker W; Schomann E; Fischbach W; Börner W; Gruner KR
    Nucl Med Commun; 1988 Jun; 9(6):435-47. PubMed ID: 3137513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative study of 99Tcm-HMPAO and 99Tcm-ECD as a leukocyte labelling agent.
    Kao CH; Huang WT; Wang YL; Lin KS; Lo JM; Wang SJ
    Nucl Med Commun; 1994 Apr; 15(4):294-7. PubMed ID: 8072744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative study of 99Tcm-d,l-HMPAO and 99Tcm-d,l-CBPAO as leukocyte-labelling agents.
    Tsai CS; Kao CH; Yeh SJ; Wang SJ
    Nucl Med Commun; 1996 Jan; 17(1):76-9. PubMed ID: 8692477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new 99mTc labelling method for leucocytes: in vitro and in vivo comparison with 99mTc-HMPAO.
    Welling M; Feitsma HI; Blok D; Calame W; Ensing GJ; Goedemans W; Pauwels EK
    Q J Nucl Med; 1995 Jun; 39(2):89-98. PubMed ID: 8574810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging inflammation with 99Tcm HMPAO labelled leucocytes.
    Reynolds JH; Graham D; Smith FW
    Clin Radiol; 1990 Sep; 42(3):195-8. PubMed ID: 2208930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 99Tcm-labelled leucocyte imaging in active rheumatoid arthritis.
    Al-Janabi MA; Jones AK; Solanki K; Sobnack R; Bomanji J; Al-Nahhas AA; Doyle DV; Britton KE; Huskisson EC
    Nucl Med Commun; 1988 Dec; 9(12):987-91. PubMed ID: 3217068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of 123I monoclonal granulocyte antibody and 99Tcm-HMPAO-labelled leucocytes in the detection of inflammation.
    Vorne M; Karhunen K; Lantto T; Mokka R; Mäkelä P; Nikoskelainen J; Rajamäki A
    Nucl Med Commun; 1988 Sep; 9(9):623-9. PubMed ID: 3186083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 99Tcm-exametazime-labelled leucocytes: effect of volume and concentration of exametazime on labelling efficiency, and clinical protocol for high efficiency multi-dose radiolabelling.
    Sampson CB; Solanki C; Barber RW
    Nucl Med Commun; 1991 Aug; 12(8):719-23. PubMed ID: 1780111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An in vitro study to compare 99mTc-stannous colloids and 99mTc-HMPAO for labelling human leukocytes.
    Capriotti G; D'Alessandria C; Garin E; Weber E; Devillers A; Lehmann K; Corsetti F; Lecloirec J; Meller J; Becker W; Moisan A; Signore A
    Q J Nucl Med Mol Imaging; 2004 Sep; 48(3):229-36. PubMed ID: 15499297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of alternative reconstitution procedures on the labelling efficiency and in vitro stability of 99Tcm-labelled radiopharmaceuticals.
    Bogsrud TV; Chen MN; Herold TJ; Mahoney DW; Hung JC
    Nucl Med Commun; 1999 Jan; 20(1):61-5. PubMed ID: 9949414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical experience with 99mTc-hexamethylpropylene-amineoxime for labelling leucocytes and imaging inflammation.
    Peters AM; Danpure HJ; Osman S; Hawker RJ; Henderson BL; Hodgson HJ; Kelly JD; Neirinckx RD; Lavender JP
    Lancet; 1986 Oct; 2(8513):946-9. PubMed ID: 2877132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of 99m technetium hexamethylpropylene-amine oxime labelled leucocyte with 111-indium tropolonate labelled granulocyte scanning and ultrasound in the diagnosis of intra-abdominal abscess.
    Weldon MJ; Joseph AE; French A; Saverymuttu SH; Maxwell JD
    Gut; 1995 Oct; 37(4):557-64. PubMed ID: 7489945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiolabelled mixed leukocytes and pure granulocytes with stabilized 99Tcm-exametazime.
    Hung JC; Chowdhury S; Mahoney DW; Mullan BP
    Nucl Med Commun; 1998 Oct; 19(10):981-7. PubMed ID: 10234678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Technetium-99m and indium-111 double labelling of granulocytes for kinetic and clinical studies.
    Aktolun C; Ussov WY; Arka A; Glass D; Gunasekera RD; Peters AM
    Eur J Nucl Med; 1995 Apr; 22(4):330-4. PubMed ID: 7607263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a new leukocyte labeling procedure with 99mTc-HMPAO.
    Kelbaek H; Linde J; Nielsen SL
    Eur J Nucl Med; 1988; 14(12):621-3. PubMed ID: 3243309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New synthesis route of active substance d,l-HMPAO for preparation Technetium Tc99m Exametazime.
    Pijarowska-Kruszyna J; Karczmarczyk U; Jaroń AW; Laszuk E; Radzik M; Garnuszek P; Mikołajczak R
    Nucl Med Rev Cent East Eur; 2017; 20(2):88-94. PubMed ID: 28555448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.